Suchergebnisse - "Goeckenjan, Maren"

PubPharm (5)

1

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

2

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

3

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

4

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

5

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 24 April 2017

von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +9

1
[1]